Cargando…
Induced Native Phage Therapy for the Treatment of Lyme Disease and Relapsing Fever: A Retrospective Review of First 14 Months in One Clinic
The overall failure rate of standard therapeutic options for late/chronic/persistent borreliosis emphasizes the need for novel therapeutic strategies. In this report, we are presenting a novel therapeutic option based on a new technology, Induced Native Phage Therapy (INPT; PhagenCorp, LLC, Sarasota...
Autores principales: | Jernigan, David A, Hart, Martin C, Dodd, Keeley K, Jameson, Samuel, Farney, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636187/ https://www.ncbi.nlm.nih.gov/pubmed/34873551 http://dx.doi.org/10.7759/cureus.20014 |
Ejemplares similares
-
Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options
por: Talbot, Norris C, et al.
Publicado: (2023) -
Protocol for a longitudinal cohort study of Lyme disease with physical, mental and immunological assessment
por: Loeb, Mark, et al.
Publicado: (2023) -
Lyme Borreliosis as a Trigger for Autoimmune Disease
por: Yehudina, Yelyzaveta, et al.
Publicado: (2021) -
Incidence of Lyme disease in the UK: a population-based cohort study
por: Cairns, Victoria, et al.
Publicado: (2019) -
Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium
por: Willems, Ruben, et al.
Publicado: (2023)